Close
We consider the collection of safety information regarding pharmaceutical...
We provide training for all employees involved in promotion activities to...
As part of Deciphera’s Global All Company Meeting in October 2025, em...
When newly appointing third parties, such as contractors or agents, we co...
We have participated in Relay for Life (RFL) as a part of our social co...
As for water risks, the Environmental Management Committee and the Nature...
Our stakeholders include patients, healthcare professionals, shareholde...
We support the purpose of the children’s invitational perfo...
An abundant global environment (ecosystem) not only provides food, wate...
We have been donating and providing research grants to public interest in...
The total volume of our industrial waste in FY2025 was 479.8 tons, a 338....
Compliance Promotion System To strengthen our compliance system, we ha...
Guided by its corporate philosophy, “Dedicated to the Fight aga...
We recognize our responsibility, as a pharmaceutical company involved in ...
The materiality analysis implemented in FY2021 was conducted using the...
We have established a Sales Information Activities Supervisory Division w...
Governance This structure is as of Jul...
Since 2023, ONO has been participating in Access Accelerated, a global pa...
Our efforts to promote diversity focus on three main areas: management*, ...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
The total water withdrawal in FY2025 was 186.0 thousand m3, a reduction ...
In November 2017, we participated in the United Nations Global Compact (U...
With the aim of increasing children’s interest in science, experiments,...
Risk Management Business Continuity Plan (BCP) Major Risks Infor...
